HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Over The Counter 22 Aug 2022: Psychedelic Mushrooms With Alkemist Lab CEO Elan Sudberg

Executive Summary

In this episode, HBW Insight speaks to Elan Sudberg, CEO of Alkemist Labs and chair of the American Herbal Product Association’s Psychedelic Plants and Fungi committee. Sudberg talks about the founding of the committee and the regulatory hoops that companies will have to jump through to research and develop psychedelic supplements, as well as the benefits that psychedelic plants are thought to have on human health.


Further Reading

For New Mushroom Supplement Line, Gaia Herbs Goes To Oldest Source For Ingredients

Psychedelics Pipeline Overview: R&D Blossoms But No Panacea Among Candidates

More De-Risking Required Before Pharma Dives Into Psychedelics

Partnership In Israel Cultivates Combining Cannabis And Mushrooms For Supplements

EU Novel Food Approvals: Yes To Vit D Mushroom Powder, No To New Zinc Source

Further Listening

These and all other podcasts are available on the Informa Pharma Intelligence channel on Apple PodcastsGoogle PodcastsSoundCloud and TuneIn - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider. 

Over The Counter Theme Music:

Modern Chillout by penguinmusic.

Copyright 2021 Licensed under a commercial Pixabay License.

 

 

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152851

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel